The third day of the conference focused on stem cells, new small molecule screens, poster sessions and clinical trial updates. Hirofumi Komaki (National Center of Neurology and Psychiatry, Japan) presented results of a Japanese Phase I/II dose-finding clinical study with NS-065, an exon-53 skipping drug (NS Pharma) for the treatment of Duchenne. The drug was […]
Are you looking for a physical therapist who is specially trained to care for your loved one with Duchenne?Find CureDuchenne Cares Certified PTs across the nation
Have a story to tell that will inspire or a resource to share that would be helpful to the Duchenne community?